Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Evelo Biosciences, Inc. (EVLO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
7 Nov 2023
Bodmer Mark
CSO, President of R&D, Officer
Evelo Biosciences, Inc.
(EVLO)
25,732
-10%
3,163
$0.33
$1,043.79
SELL
7 Nov 2023
McHale Duncan
Chief Medical Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
16,984
-15%
3,103
$0.33
$1,023.99
SELL
7 Nov 2023
GILL SIMBA
President & CEO, Director, Officer
Evelo Biosciences, Inc.
(EVLO)
17,758
-0%
172
$0.33
$56.76
SELL
7 Nov 2023
Thorell Marella
Chief Financial Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
22,259
-7%
1,811
$0.33
$597.63
SELL
1 Nov 2023
Bodmer Mark
CSO, President of R&D, Officer
Evelo Biosciences, Inc.
(EVLO)
22,270
-23%
6,854
$0.33
$2,261.82
SELL
1 Nov 2023
McHale Duncan
Chief Medical Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
13,587
-33%
6,854
$0.33
$2,261.82
SELL
1 Nov 2023
Thorell Marella
Chief Financial Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
17,570
-18%
3,999
$0.33
$1,319.67
SELL
7 Aug 2023
McHale Duncan
Chief Medical Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
7,941
-30%
3,434
$9.51
$32,657.34
SELL
7 Aug 2023
Thorell Marella
Chief Financial Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
9,069
-18%
2,004
$9.51
$19,058.04
SELL
7 Aug 2023
Bodmer Mark
CSO, President of R&D, Officer
Evelo Biosciences, Inc.
(EVLO)
16,624
-15%
3,128
$9.51
$29,747.28
SELL
7 Aug 2023
GILL SIMBA
President & CEO, Director, Officer
Evelo Biosciences, Inc.
(EVLO)
3,754
-8%
342
$9.51
$3,252.42
BUY
11 Jul 2023
Flagship Ventures Fund IV General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
1,461,795
+137%
5,411,255
$2.31
$12,499,998.00
SELL
23 May 2023
Bodmer Mark
CSO, President of R&D, Officer
Evelo Biosciences, Inc.
(EVLO)
262,557
-7%
22,571
$0.14
$3,200.57
SELL
19 Jan 2023
CARRIERE STEPHEN J
Principal Accounting Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
203
-42%
151
$1.06
$160.12
BUY
27 May 2022
Flagship Ventures Fund IV General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
7,590,873
+138%
27,397,260
$1.46
$40,000,000.00
BUY
27 May 2022
McHale Duncan
Chief Medical Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
34,246
+100%
34,246
$1.46
$49,999.16
BUY
27 May 2022
Darzi Lord Ara
Director
Evelo Biosciences, Inc.
(EVLO)
342,465
+100%
342,465
$1.46
$499,998.90
BUY
27 May 2022
Epstein David R
Director
Evelo Biosciences, Inc.
(EVLO)
84,080
+25%
17,123
$1.46
$24,999.58
BUY
2 Feb 2021
Flagship Ventures Fund IV General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
3,207,312
+4%
130,000
$15.00
$1,950,000.00
BUY
11 Dec 2020
Epstein David R
Director
Evelo Biosciences, Inc.
(EVLO)
10,200
+308%
7,700
$6.66
$51,260.80
SELL
1 Dec 2020
Liu Xiaoli Jacqueline
Principal Accounting Officer, Officer
Evelo Biosciences, Inc.
(EVLO)
0
-100%
3,000
$5.17
$15,510.00
BUY
28 Aug 2020
Epstein David R
Director
Evelo Biosciences, Inc.
(EVLO)
7,000
+333%
10,000
$4.44
$44,435.12
BUY
29 Jun 2020
Flagship Ventures Fund IV General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
3,170,169
+311%
4,666,666
$3.75
$17,499,998.00
BUY
11 May 2018
Flagship Ventures Fund IV General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
18,233,404
+1%
281,250
$16.00
$4,500,000.00
BUY
11 May 2018
Flagship Ventures Fund V General Partner LLC
10% Owner
Evelo Biosciences, Inc.
(EVLO)
18,233,404
+1%
281,250
$16.00
$4,500,000.00
Home